The information in this preliminary
pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it
seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to completion dated September
27, 2016
October , 2016
|
Registration Statement Nos. 333-209682 and
333-209682-01; Rule 424(b)(2)
|
JPMorgan Chase Financial
Company LLC
Structured Investments
Review Notes Linked to the Lesser Performing
of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF due October 12, 2020
Fully and Unconditionally Guaranteed by JPMorgan
Chase & Co.
|
·
|
The notes are designed for investors who seek early exit
prior to maturity at a premium if, on any Review Date, the closing price of one share of each of the iShares
®
MSCI
Emerging Markets ETF and the iShares
®
China Large-Cap ETF, which we refer to as the Funds, is at or above its Call
Level.
|
|
·
|
The notes are also designed for investors who seek a fixed
return at maturity equal to the Contingent Minimum Return of 10.00% if the notes have not been automatically called and the Final
Value of each Fund is greater than or equal to 60.00% of its Initial Value.
|
|
·
|
Investors in the notes should be willing to forgo interest
and dividend payments and be willing to accept the risk of losing some or all of their principal.
|
|
·
|
The notes are unsecured and unsubordinated obligations
of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally
guaranteed by JPMorgan Chase & Co.
Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer
of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes.
|
|
·
|
Payments on the notes are not linked to a basket composed
of the Funds. Payments on the notes are linked to the performance of each of the Funds individually, as described below.
|
|
·
|
Minimum denominations of $10,000 and integral multiples
of $1,000 in excess thereof
|
|
·
|
The notes are expected to price on or about October 7,
2016 and are expected to settle on or about October 14, 2016.
|
Investing in the notes involves a number of risks. See “Risk
Factors” beginning on page PS-10 of the accompanying product supplement, “Risk Factors” beginning on page US-2
of the accompanying underlying supplement and “Selected Risk Considerations” beginning on page PS-4 of this pricing
supplement.
Neither the Securities and Exchange Commission (the “SEC”)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this
pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation
to the contrary is a criminal offense.
|
Price to Public (1)
|
Fees and Commissions (2)
|
Proceeds to Issuer
|
Per note
|
$1,000
|
$
|
$
|
Total
|
$
|
$
|
$
|
(1) See “Supplemental Use of Proceeds”
in this pricing supplement for information about the components of the price to public of the notes.
(2) J.P. Morgan Securities LLC, which we refer
to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to other affiliated
or unaffiliated dealers. If the notes priced today, the selling commissions would be approximately $21.50 per $1,000 principal
amount note and in no event will these selling commissions exceed $24.00 per $1,000 principal amount note. See “Plan of Distribution
(Conflicts of Interest)” in the accompanying product supplement.
|
If the notes priced today, the estimated value of the
notes would be approximately $956.90 per $1,000 principal amount note. The estimated value of the notes, when the terms of the
notes are set, will be provided in the pricing supplement and will not be less than $945.00 per $1,000 principal amount note. See
“The Estimated Value of the Notes” in this pricing supplement for additional information.
The notes are not bank deposits, are not insured by the Federal
Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.
Pricing supplement to product supplement no 4-I
dated April 15, 2016, underlying supplement no. 1-I dated April 15, 2016
and the prospectus and prospectus supplement, each dated April 15, 2016
Key
Terms
Issuer:
JPMorgan Chase Financial Company LLC
Guarantor:
JPMorgan Chase & Co.
Funds:
The
iShares
®
MSCI Emerging Markets ETF (Bloomberg ticker: EEM) and the iShares
®
China Large-Cap ETF (Bloomberg
ticker: FXI)
Call Premium
Amount:
The Call Premium Amount with respect to each Review Date is
set forth below:
·
first Review Date:
|
at least 12.00% × $1,000
|
·
second Review Date:
|
at least 24.00% × $1,000
|
·
third Review Date:
|
at least 36.00% × $1,000
|
·
final Review Date:
|
at least 48.00% × $1,000
|
(in each case, to be provided in the pricing supplement)
Call Value:
With respect to each Fund, 100.00% of its Initial Value
Contingent
Minimum Return:
10.00%
Trigger Value:
With respect to each Fund, 60.00% of its Initial Value
Pricing
Date:
On or about October 7, 2016
Original Issue
Date (Settlement Date):
On or about October 14, 2016
Review Dates*:
October 17, 2017, October 9, 2018, October 7, 2019 and October
7, 2020 (final Review Date)
Call Settlement
Dates*:
If the notes are automatically called on any Review Date, the
third business day after that Review Date, except that the final Call Settlement Date is the Maturity Date
Maturity Date*:
October 12, 2020
* Subject to postponement in the event of a market disruption
event and as described under “General Terms of Notes — Postponement of a Determination Date — Notes Linked to
Multiple Underlyings” and “General Terms of Notes — Postponement of a Payment Date” in the accompanying
product supplement
Automatic Call:
If the closing price of one share of each Fund on any Review Date
is greater than or equal to its Call Value, the notes will be automatically called for a cash payment, for each $1,000 principal
amount note, equal to (a) $1,000
plus
(b) the Call Premium Amount applicable to that Review Date, payable on the applicable
Call Settlement Date. No further payments will be made on the notes.
Payment at Maturity:
If the notes have not been automatically called and the Final
Value of each Fund is greater than or equal to its Trigger Value, your payment at maturity per $1,000 principal amount note will
be calculated as follows:
$1,000 + ($1,000 × Contingent Minimum
Return)
If the notes
have not been automatically called and the Final Value of either Fund is less than its Trigger Value,
your
payment at maturity per $1,000 principal amount note will be calculated as follows:
$1,000 + ($1,000 × Lesser Performing
Fund Return)
If the notes have not been
automatically called and the Final Value of either Fund is less than its Trigger Value, you will lose more than 40.00% of your
principal amount at maturity and could lose all of your principal amount at maturity.
Lesser Performing
Fund:
The Fund with the Lesser Performing Fund Return
Lesser Performing
Fund Return:
The lower of the Fund Returns of the Funds
Fund Return:
With respect to each Fund,
(Final Value – Initial Value)
Initial Value
Initial Value:
With respect to each Fund, the closing price of one share of that Fund
on the Pricing Date
Final Value:
With respect to each Fund, the closing price of one share of that Fund
on the final Review Date
Share Adjustment
Factor:
With respect to each Fund, the Share Adjustment Factor is referenced in determining
the closing price of one share of that Fund and is set equal to 1.0 on the Pricing Date. The Share Adjustment Factor of each Fund
is subject to adjustment upon the occurrence of certain events affecting that Fund. See “The Underlyings — Funds —
Anti-Dilution Adjustments” in the accompanying product supplement for further information.
PS-
1
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
How
the Notes Work
Payment upon an Automatic Call
Payment at Maturity If the Notes Have Not
Been Automatically Called
Call Premium Amount
The table below illustrates the hypothetical Call
Premium Amount per $1,000 principal amount note for each Review Date based on the minimum Call Premium Amounts set forth under
“Key Terms — Call Premium Amount” above. The actual Call Premium Amounts will be provided in the pricing supplement
and will be not less than the minimum Call Premium Amounts set forth under “Key Terms — Call Premium Amount.”
Review Date
|
Call Premium Amount
|
First
|
$120.00
|
Second
|
$240.00
|
Third
|
$360.00
|
Final
|
$480.00
|
Hypothetical
Payout Examples
The following examples illustrate payments on
the notes linked to two hypothetical Funds, assuming a range of performances for the hypothetical Lesser Performing Fund on the
Review Dates.
Each hypothetical payment set forth below assumes that the closing price of one share of the Fund that is not
the Lesser Performing Fund on each Review Date is greater than or equal to its Call Value (and therefore its Trigger Value).
PS-
2
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
In addition, the hypothetical payments set forth
below assume the following:
|
·
|
an Initial Value for the Lesser Performing Fund of $100.00;
|
|
·
|
a Call Value for the Lesser Performing Fund of $100.00
(equal to 100.00% of the hypothetical Initial Value);
|
|
·
|
a Trigger Value for the Lesser Performing Fund of $60.00
(equal to 60.00% of the hypothetical Initial Value); and
|
|
·
|
the Call Premium Amounts are equal to the minimum Call
Premium Amounts set forth under “Key Terms — Call Premium Amount” above.
|
The hypothetical Initial Value of the Lesser Performing
Fund of $100.00 has been chosen for illustrative purposes only and may not represent a likely actual Initial Value of either Fund.
The actual Initial Value of each Fund will be the closing price of one share of that Fund on the Pricing Date and will be provided
in the pricing supplement. For historical data regarding the actual closing prices of one share of each Fund, please see the historical
information set forth under “The Funds” in this pricing supplement.
Each hypothetical payment set forth below is
for illustrative purposes only and may not be the actual payment applicable to a purchaser of the notes. The numbers appearing
in the following examples have been rounded for ease of analysis.
Example 1 — Notes are automatically
called on the first Review Date.
Date
|
Closing Price of Lesser Performing Fund
|
|
First Review Date
|
$110.00
|
Notes are automatically called
|
|
Total Payment
|
$1,120.00 (12.00% return)
|
Because the closing price of one share of each
Fund on the first Review Date is greater than or equal to its Call Value, the notes will be automatically called for a cash payment,
for each $1,000 principal amount note, of $1,120.00 (or $1,000
plus
the Call Premium Amount applicable to the first Review
Date), payable on the applicable Call Settlement Date. No further payments will be made on the notes.
Example 2 — Notes are automatically
called on the final Review Date.
Date
|
Closing Price of Lesser Performing Fund
|
|
First Review Date
|
$90.00
|
Notes NOT automatically called
|
Second Review Date
|
$85.00
|
Notes NOT automatically called
|
Third Review Date
|
$95.00
|
Notes NOT automatically called
|
Final Review Date
|
$110.00
|
Notes are automatically called
|
|
Total Payment
|
$1,480.00 (48.00% return)
|
Because the closing price of one share of each
Fund on the final Review Date is greater than or equal to its Call Value, the notes will be automatically called for a cash payment,
for each $1,000 principal amount note, of $1,480.00 (or $1,000
plus
the Call Premium Amount applicable to the final Review
Date), payable on the applicable Call Settlement Date. No further payments will be made on the notes.
Example 3 — Notes have NOT been automatically
called and the Final Value of the Lesser Performing Fund is greater than or equal to its Trigger Value.
Date
|
Closing Price of Lesser Performing Fund
|
|
First Review Date
|
$90.00
|
Notes NOT automatically called
|
Second Review Date
|
$85.00
|
Notes NOT automatically called
|
Third Review Date
|
$95.00
|
Notes NOT automatically called
|
Final Review Date
|
$70.00
|
Notes NOT automatically called; Final Value of Lesser Performing Fund is greater than or equal to Trigger Value
|
|
Total Payment
|
$1,100.00 (10.00% return)
|
Because the notes have not been automatically
called and the Final Value of the Lesser Performing Fund is greater than or equal to its Trigger Value, the payment at maturity,
for each $1,000 principal amount note, will be $1,100.00, calculated as follows:
$1,000 + ($1,000 × 10.00%) = $1,100.00
PS-
3
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
Example 4 — Notes have NOT been automatically
called and the Final Value of the Lesser Performing Fund is less than its Trigger Value.
Date
|
Closing Price of Lesser Performing Fund
|
|
First Review Date
|
$80.00
|
Notes NOT automatically called
|
Second Review Date
|
$70.00
|
Notes NOT automatically called
|
Third Review Date
|
$60.00
|
Notes NOT automatically called
|
Final Review Date
|
$50.00
|
Notes NOT automatically called; Final Value of Lesser Performing Fund is less than Trigger Value
|
|
Total Payment
|
$500.00 (-50.00% return)
|
Because the notes have not been automatically
called, the Final Value of the Lesser Performing Fund is less than its Trigger Value and the Lesser Performing Fund Return is -50.00%,
the payment at maturity will be $500.00 per $1,000 principal amount note, calculated as follows:
$1,000 + [$1,000 × (-50.00%)
]
= $500.00
The hypothetical returns and hypothetical payments
on the notes shown above apply
only if you hold the notes for their entire term or until automatically called.
These hypotheticals
do not reflect the fees or expenses that would be associated with any sale in the secondary market. If these fees and expenses
were included, the hypothetical returns and hypothetical payments shown above would likely be lower.
Selected
Risk Considerations
An investment in the notes involves significant
risks. These risks are explained in more detail in the “Risk Factors” sections of the accompanying product supplement
and underlying supplement.
|
·
|
YOUR INVESTMENT IN THE NOTES MAY RESULT IN A LOSS —
|
The notes do not guarantee any return
of principal. If the notes have not been automatically called and the Final Value of either Fund is less than its Trigger Value,
you will lose 1% of the principal amount of your notes for every 1% that the Final Value of the Lesser Performing Fund is less
than its Initial Value. Accordingly, under these circumstances, you will lose more than 40.00% of your principal amount at maturity
and could lose all of your principal amount at maturity.
|
·
|
CREDIT RISKS OF JPMORGAN FINANCIAL AND JPMORGAN CHASE & CO. —
|
Investors are dependent on our and
JPMorgan Chase & Co.’s ability to pay all amounts due on the notes. Any actual or potential change in our or JPMorgan
Chase & Co.’s creditworthiness or credit spreads, as determined by the market for taking that credit risk, is likely
to adversely affect the value of the notes. If we and JPMorgan Chase & Co. were to default on our payment obligations, you
may not receive any amounts owed to you under the notes and you could lose your entire investment.
|
·
|
AS A FINANCE SUBSIDIARY, JPMORGAN FINANCIAL HAS NO INDEPENDENT OPERATIONS AND HAS LIMITED ASSETS
—
|
As a finance subsidiary of JPMorgan
Chase & Co., we have no independent operations beyond the issuance and administration of our securities. Aside from the initial
capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of our affiliates to
make payments under loans made by us or other intercompany agreements. As a result, we are dependent upon payments from our affiliates
to meet our obligations under the notes. If these affiliates do not make payments to us and we fail to make payments on the notes,
you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and that guarantee will rank
pari passu
with all other unsecured and unsubordinated obligations of JPMorgan Chase & Co.
|
·
|
THE APPRECIATION POTENTIAL OF THE NOTES IS LIMITED TO ANY CALL PREMIUM AMOUNT PAID ON THE NOTES
IF THE NOTES ARE AUTOMATICALLY CALLED,
|
regardless of any appreciation in the
price of one share of either Fund, which may be significant. You will not participate in any appreciation in the price of one share
of either Fund.
PS-
4
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
|
·
|
YOUR ABILITY TO RECEIVE THE CONTINGENT MINIMUM RETURN MAY TERMINATE ON THE FINAL REVIEW DATE IF
THE NOTES HAVE NOT BEEN AUTOMATICALLY CALLED
—
|
If the notes have not been automatically
called and the Final Value of either Fund is less than its Trigger Value, you will not be entitled to receive the Contingent Minimum
Return at maturity. Under these circumstances, you may lose some or all of your principal amount at maturity.
We and our affiliates play a variety
of roles in connection with the notes. In performing these duties, our and JPMorgan Chase & Co.’s economic interests
are potentially adverse to your interests as an investor in the notes. It is possible that hedging or trading activities of ours
or our affiliates in connection with the notes could result in substantial returns for us or our affiliates while the value of
the notes declines. Please refer to “Risk Factors — Risks Relating to Conflicts of Interest” in the accompanying
product supplement.
|
·
|
YOU ARE EXPOSED TO THE RISK OF DECLINE IN THE PRICE OF EACH FUND —
|
Payments on the notes are not linked
to a basket composed of the Funds and are contingent upon the performance of each individual Fund. Poor performance by either of
the Funds over the term of the notes may result in the notes not being automatically called on a Review Date, may negatively affect
your payment at maturity and will not be offset or mitigated by positive performance by the other Fund.
|
·
|
YOUR PAYMENT AT MATURITY MAY BE DETERMINED BY THE LESSER PERFORMING FUND.
|
|
·
|
THE BENEFIT PROVIDED BY THE TRIGGER VALUE MAY TERMINATE ON THE FINAL REVIEW DATE —
|
If the Final Value of either Fund is
less than its Trigger Value and the notes have not been automatically called, the benefit provided by the Trigger Value will terminate
and you will be fully exposed to any depreciation in the closing price of one share of the Lesser Performing Fund.
|
·
|
THE AUTOMATIC CALL FEATURE MAY FORCE A POTENTIAL EARLY EXIT —
|
If your notes are automatically called,
the term of the notes may be reduced to as short as approximately one year. There is no guarantee that you would be able to reinvest
the proceeds from an investment in the notes at a comparable return for a similar level of risk. Even in cases where the notes
are called before maturity, you are not entitled to any fees and commissions described on the front cover of this pricing supplement.
|
·
|
YOU WILL NOT RECEIVE DIVIDENDS ON EITHER FUND OR THE SECURITIES HELD BY EITHER FUND OR HAVE ANY
RIGHTS WITH RESPECT TO THE FUNDS OR THOSE SECURITIES.
|
|
·
|
THERE ARE RISKS ASSOCIATED WITH THE FUNDS —
|
The
Funds are subject to management risk, which is the risk that the investment strategies of the applicable Fund’s investment
adviser, the implementation of which is subject to a number of constraints, may not produce the intended results. These constraints
could adversely affect the market prices of the shares of the Funds and, consequently, the value of the notes.
|
·
|
THE PERFORMANCE AND MARKET VALUE OF EACH FUND, PARTICULARLY DURING PERIODS OF MARKET VOLATILITY, MAY NOT CORRELATE WITH
THE PERFORMANCE OF THAT FUND’S UNDERLYING INDEX AS WELL AS THE NET ASSET VALUE PER SHARE —
|
Each Fund does not fully replicate
its Underlying Index (as defined under “The Funds” below) and may hold securities different from those included in
its Underlying Index. In addition, the performance of each Fund will reflect additional transaction costs and fees that are not
included in the calculation of its Underlying Index. All of these factors may lead to a lack of correlation between the performance
of each Fund and its Underlying Index. In addition, corporate actions with respect to the equity securities underlying a Fund (such
as mergers and spin-offs) may impact the variance between the performances of that Fund and its Underlying Index. Finally, because
the shares of each Fund are traded on a securities exchange and are subject to market supply and investor demand, the market value
of one share of each Fund may differ from the net asset value per share of that Fund. During periods of market volatility, securities
underlying each Fund may be unavailable in the secondary market, market participants may be unable to calculate accurately the
net asset value per share of that Fund and the liquidity of that Fund may be adversely affected. This kind of market volatility
may also disrupt the ability of market participants to create and redeem shares of a Fund. Further, market volatility may adversely
affect, sometimes materially, the prices at which market participants are willing to buy and sell shares of that Fund. As a result,
under these circumstances, the market value of shares of a Fund may vary substantially from the net asset value per share of that
Fund. For all of the foregoing reasons, the performance of each Fund may
PS-
5
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
not correlate with the performance
of its Underlying Index as well as the net asset value per share of that Fund, which could materially and adversely affect the
value of the notes in the secondary market and/or reduce any payment on the notes.
|
·
|
NON-U.S. SECURITIES RISK —
|
The
equity securities held by each Fund have been issued by non-U.S. companies. Investments in securities linked to the value of non-U.S.
equity securities involve risks associated with the securities markets in the home countries of the issuers of those non-U.S. equity
securities. Also, there is generally less publicly available information about companies in some of these jurisdictions than there
is about U.S. companies that are subject to the reporting requirements of the SEC.
|
·
|
EMERGING MARKETS RISK —
|
The
equity securities held by each fund
have been issued by non-U.S. companies located in
emerging markets countries. Countries with emerging markets may have relatively unstable governments, may present the risks
of nationalization of businesses, restrictions on foreign ownership and prohibitions on the repatriation of assets, and may have
less protection of property rights than more developed countries. The economies of countries with emerging markets may be
based on only a few industries, may be highly vulnerable to changes in local or global trade conditions, and may suffer from extreme
and volatile debt burdens or inflation rates. Local securities markets may trade a small number of securities and may be
unable to respond effectively to increases in trading volume, potentially making prompt liquidation of holdings difficult or impossible
at times.
|
·
|
THE NOTES ARE SUBJECT TO CURRENCY EXCHANGE RISK —
|
Because the prices of the equity securities
held by each Fund are converted into U.S. dollars for purposes of calculating the net asset value of that Fund, holders of the
notes will be exposed to currency exchange rate risk with respect to each of the currencies in which the equity securities held
by that Fund trade. Your net exposure will depend on the extent to which those currencies strengthen or weaken against the U.S.
dollar and the relative weight of equity securities held by a Fund denominated in each of those currencies. If, taking into account
the relevant weighting, the U.S. dollar strengthens against those currencies, the price of a Fund will be adversely affected and
any payment on the notes may be reduced.
|
·
|
THE ANTI-DILUTION PROTECTION FOR THE FUNDS IS LIMITED —
|
The calculation agent will make adjustments
to the Share Adjustment Factor for each Fund for certain events affecting the shares of that Fund. However, the calculation agent
will not make an adjustment in response to all events that could affect the shares of the Funds. If an event occurs that does not
require the calculation agent to make an adjustment, the value of the notes may be materially and adversely affected.
|
·
|
THE RISK OF THE CLOSING PRICE OF ONE SHARE OF A FUND FALLING BELOW ITS TRIGGER VALUE IS GREATER
IF THE PRICE OF ONE SHARE OF THAT FUND IS VOLATILE.
|
The notes will not be listed on any
securities exchange. Accordingly, the price at which you may be able to trade your notes is likely to depend on the price, if any,
at which JPMS is willing to buy the notes. You may not be able to sell your notes. The notes are not designed to be short-term
trading instruments. Accordingly, you should be able and willing to hold your notes to maturity.
|
·
|
THE FINAL TERMS AND VALUATION OF THE NOTES WILL BE PROVIDED IN THE PRICING SUPPLEMENT —
|
You should consider your potential
investment in the notes based on the minimums for the estimated value of the notes and the Call Premium Amounts.
|
·
|
THE ESTIMATED VALUE OF THE NOTES WILL BE LOWER THAN THE ORIGINAL ISSUE PRICE (PRICE TO PUBLIC)
OF THE NOTES —
|
The estimated value of the notes is
only an estimate determined by reference to several factors. The original issue price of the notes will exceed the estimated value
of the notes because costs associated with selling, structuring and hedging the notes are included in the original issue price
of the notes. These costs include the selling commissions, the projected profits, if any, that our affiliates expect to realize
for assuming risks inherent in hedging our obligations under the notes and the estimated cost of hedging our obligations under
the notes. See “The Estimated Value of the Notes” in this pricing supplement.
|
·
|
THE ESTIMATED VALUE OF THE NOTES DOES NOT REPRESENT FUTURE VALUES OF THE NOTES AND MAY DIFFER
FROM OTHERS’ ESTIMATES —
|
See “The Estimated Value of the
Notes” in this pricing supplement.
PS-
6
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
|
·
|
THE ESTIMATED VALUE OF THE NOTES IS DERIVED BY REFERENCE TO AN INTERNAL FUNDING RATE —
|
The internal
funding rate used in the determination of the estimated value of the notes is based on, among other things, our and our affiliates’
view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the
notes
in comparison to those costs for the conventional fixed-rate debt of JPMorgan Chase
& Co
. The use of an internal funding rate and any potential changes to that rate may have
an adverse effect on the terms of the notes and any secondary market prices of the notes. See “The Estimated Value of the
Notes” in this pricing supplement.
|
·
|
THE VALUE OF THE NOTES AS PUBLISHED BY JPMS (AND WHICH MAY BE REFLECTED ON CUSTOMER ACCOUNT STATEMENTS)
MAY BE HIGHER THAN THE THEN-CURRENT ESTIMATED VALUE OF THE NOTES FOR A LIMITED TIME PERIOD —
|
We generally expect that some of the
costs included in the original issue price of the notes will be partially paid back to you in connection with any repurchases of
your notes by JPMS in an amount that will decline to zero over an initial predetermined period. See “Secondary Market Prices
of the Notes” in this pricing supplement for additional information relating to this initial period. Accordingly, the estimated
value of your notes during this initial period may be lower than the value of the notes as published by JPMS (and which may be
shown on your customer account statements).
|
·
|
SECONDARY MARKET PRICES OF THE NOTES WILL LIKELY BE LOWER THAN THE ORIGINAL ISSUE PRICE OF THE
NOTES —
|
Any secondary market prices of the
notes will likely be lower than the original issue price of the notes because, among other things, secondary market prices take
into account our internal secondary market funding rates for structured debt issuances and, also, because secondary market prices
(a) exclude selling commissions and (b) may exclude projected hedging profits, if any, and estimated hedging costs that are included
in the original issue price of the notes. As a result, the price if any, at which JPMS will be willing to buy the notes from you
in secondary market transactions, if at all, is likely to be lower than the original issue price. Any sale by you prior to the
Maturity Date could result in a substantial loss to you.
|
·
|
SECONDARY MARKET PRICES OF THE NOTES WILL BE IMPACTED BY MANY ECONOMIC AND MARKET FACTORS —
|
The secondary market price of the notes
during their term will be impacted by a number of economic and market factors, which may either offset or magnify each other, aside
from the selling commissions projected hedging profits, if any, estimated hedging costs and the prices of the Funds. Additionally,
independent pricing vendors and/or third party broker-dealers may publish a price for the notes, which may also be reflected on
customer account statements. This price may be different (higher or lower) than the price of the notes, if any, at which JPMS may
be willing to purchase your notes in the secondary market. See “Risk Factors — Risks Relating to the Estimated Value
and Secondary Market Prices of the Notes — Secondary market prices of the notes will be impacted by many economic and market
factors” in the accompanying product supplement.
The
Funds
The iShares
®
MSCI Emerging Markets
ETF is an exchange-traded fund of iShares
®
, Inc., a registered investment company, which seeks to track the investment
results, before fees and expenses, of an index composed of large- and mid-capitalization emerging market equities, which we refer
to as the Underlying Index with respect to the iShares
®
Emerging Markets ETF. The Underlying Index for the iShares
®
Emerging Markets ETF is currently the MSCI Emerging Markets Index. The MSCI Emerging Markets Index is a free float-adjusted market
capitalization index that is designed to measure equity market performance of global emerging markets. For additional information
about the iShares
®
Emerging Markets ETF, see “Fund Descriptions — The iShares
®
ETFs”
in the accompanying underlying supplement.
The iShares
®
China Large-Cap ETF
is an exchange-traded fund of iShares
®
Trust, a registered investment company, which seeks to track the investment
results, before fees and expenses, of an index composed of large-capitalization Chinese equities that trade on the Stock Exchange
of Hong Kong, which we refer to as the Underlying Index with respect to the iShares
®
China Large-Cap ETF.
The Underlying Index for the iShares
®
China Large-Cap ETF is currently the FTSE
®
China 50 Index.
The FTSE
®
China 50 Index is designed to represent the performance of the mainland Chinese market that is available
to international investors and consists of 50 of the largest and most liquid Chinese stocks listed and traded on the Stock Exchange
of Hong Kong. For additional information about the iShares
®
China Large-Cap ETF, see “Annex A”
in this pricing supplement.
Historical Information
The following graphs set forth the historical
performance of each Fund based on the weekly historical closing prices of one share from January 7, 2011 through September 23,
2016. The closing price of one share of the iShares
®
MSCI Emerging Markets ETF on September 26, 2016 was $37.08.
The closing price of one share of the iShares
®
China Large-Cap ETF on September 26, 2016 was $37.52. We obtained
the closing prices of one share above and below from the Bloomberg Professional
®
service (“Bloomberg”),
PS-
7
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
without independent verification. The closing
values above and below may have been adjusted by Bloomberg for actions taken by the Funds, such as stock splits.
The historical closing prices of one share
of each Fund should not be taken as an indication of future performance, and no assurance can be given as to the closing price
of one share of either Fund on the Pricing Date or any Review Date. There can be no assurance that the performance of the Funds
will result in the return of any of your principal amount.
Tax
Treatment
You should review carefully the section entitled
“Material U.S. Federal Income Tax Consequences” in the accompanying product supplement no. 4-I. The following discussion,
when read in combination with that section, constitutes the full opinion of our special tax counsel, Davis Polk & Wardwell
LLP, regarding the material U.S. federal income tax consequences of owning and disposing of notes.
Based on current market
conditions, in the opinion of our special tax counsel it is reasonable to treat the notes as “open transactions” that
are not debt instruments for U.S. federal income tax purposes, as more fully described in “Material U.S. Federal Income Tax
Consequences — Tax Consequences to U.S. Holders — Notes Treated as Open Transactions That Are Not Debt Instruments”
in the accompanying product supplement. Assuming this treatment is respected, the gain or loss on your notes should be treated
as long-term capital gain or loss if you hold your notes for more than a year, whether or not you are an initial purchaser of notes
at the issue price. However, the IRS or a court may not respect this treatment, in which case the timing and character of any income
or loss on the
PS-
8
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
notes could be materially and adversely affected.
In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid
forward contracts” and similar instruments. The notice focuses in particular on whether to require investors in these instruments
to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character
of income or loss with respect to these instruments; the relevance of factors such as the nature of the underlying property to
which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors
should be subject to withholding tax; and whether these instruments are or should be subject to the “constructive ownership”
regime, which very generally can operate to recharacterize certain long-term capital gain as ordinary income and impose a notional
interest charge. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations
or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of
an investment in the notes, possibly with retroactive effect. You should consult your tax adviser regarding the U.S. federal income
tax consequences of an investment in the notes, including possible alternative treatments and the issues presented by this notice.
Withholding under legislation commonly referred
to as “FATCA” may (if the notes are recharacterized as debt instruments) apply to amounts treated as interest paid
with respect to the notes, as well as to payments of gross proceeds of a taxable disposition, including an automatic call or redemption
at maturity, of a note. However, under a recent IRS notice, this regime will not apply to payments of gross proceeds (other than
any amount treated as interest) with respect to dispositions occurring before January 1, 2019. You should consult your tax adviser
regarding the potential application of FATCA to the notes.
Non-U.S. holders should also note that recently
promulgated Treasury regulations imposing a withholding tax on certain “dividend equivalents” under certain “equity
linked instruments” will not apply to the notes.
The
Estimated Value of the Notes
The estimated value of the notes set forth
on the cover of this pricing supplement is equal to the sum of the values of the following hypothetical components: (1) a fixed-income
debt component with the same maturity as the notes, valued using the internal funding rate described below, and (2) the derivative
or derivatives underlying the economic terms of the notes. The estimated value of the notes does not represent a minimum price
at which JPMS would be willing to buy your notes in any secondary market (if any exists) at any time. The internal funding rate
used in the determination of the estimated value of the notes is based on, among other things, our and our affiliates’ view
of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes
in comparison to those costs for the conventional fixed-rate debt of JPMorgan Chase & Co. For additional information, see “Selected
Risk Considerations — The Estimated Value of the Notes Is Derived by Reference to an Internal Funding Rate” in this
pricing supplement.
The value of the derivative or derivatives
underlying the economic terms of the notes is derived from internal pricing models of our affiliates. These models are dependent
on inputs such as the traded market prices of comparable derivative instruments and on various other inputs, some of which are
market-observable, and which can include volatility, dividend rates, interest rates and other factors, as well as assumptions about
future market events and/or environments. Accordingly, the estimated value of the notes is determined when the terms of the notes
are set based on market conditions and other relevant factors and assumptions existing at that time.
The estimated value of the notes does not
represent future values of the notes and may differ from others’ estimates. Different pricing models and assumptions could
provide valuations for the notes that are greater than or less than the estimated value of the notes. In addition, market conditions
and other relevant factors in the future may change, and any assumptions may prove to be incorrect. On future dates, the value
of the notes could change significantly based on, among other things, changes in market conditions, our or JPMorgan Chase &
Co.’s creditworthiness, interest rate movements and other relevant factors, which may impact the price, if any, at which
JPMS would be willing to buy notes from you in secondary market transactions.
The estimated value of the notes will be
lower than the original issue price of the notes because costs associated with selling, structuring and hedging the notes are included
in the original issue price of the notes. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated
dealers, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations
under the notes and the estimated cost of hedging our obligations under the notes. Because hedging our obligations entails risk
and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected,
or it may result in a loss. A portion of the profits, if any, realized in hedging our obligations under the notes may be allowed
to other affiliated or unaffiliated dealers, and we or one or more of our affiliates will retain any remaining hedging
PS-
9
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
profits. See “Selected Risk Considerations
— The Estimated Value of the Notes Will Be Lower Than the Original Issue Price (Price to Public) of the Notes” in this
pricing supplement.
Secondary
Market Prices of the Notes
For information about factors that will impact
any secondary market prices of the notes, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market
Prices of the Notes — Secondary market prices of the notes will be impacted by many economic and market factors” in
the accompanying product supplement. In addition, we generally expect that some of the costs included in the original issue price
of the notes will be partially paid back to you in connection with any repurchases of your notes by JPMS in an amount that will
decline to zero over an initial predetermined period. These costs can include projected hedging profits, if any, and, in some circumstances,
estimated hedging costs and our internal secondary market funding rates for structured debt issuances. This initial predetermined
time period is intended to be the shorter of six months and one-half of the stated term of the notes. The length of any such initial
period reflects the structure of the notes, whether our affiliates expect to earn a profit in connection with our hedging activities,
the estimated costs of hedging the notes and when these costs are incurred, as determined by our affiliates. See “Selected
Risk Considerations — The Value of the Notes as Published by JPMS (and Which May Be Reflected on Customer Account Statements)
May Be Higher Than the Then-Current Estimated Value of the Notes for a Limited Time Period” in this pricing supplement.
Supplemental
Use of Proceeds
The notes are offered to meet investor demand
for products that reflect the risk-return profile and market exposure provided by the notes. See “How the Notes Work”
and “Hypothetical Payout Examples” in this pricing supplement for an illustration of the risk-return profile of the
notes and “The Funds” in this pricing supplement for a description of the market exposure provided by the notes.
The original issue price of the notes is
equal to the estimated value of the notes plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers,
plus (minus) the projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations
under the notes, plus the estimated cost of hedging our obligations under the notes.
Supplemental
Plan of Distribution
We expect that delivery of the notes will
be made against payment for the notes on or about the Original Issue Date set forth on the front cover of this pricing supplement,
which will be the fifth business day following the expected Pricing Date of the notes (this settlement cycle being referred to
as T+5). Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are
required to settle in three business days, unless the parties to that trade expressly agree otherwise. Accordingly, purchasers
who wish to trade notes on the Pricing Date or the succeeding business day will be required to specify an alternate settlement
cycle at the time of any such trade to prevent a failed settlement and should consult their own advisors.
Additional
Terms Specific to the Notes
You may revoke your offer to purchase the notes
at any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the
terms of, or reject any offer to purchase, the notes prior to their issuance. In the event of any changes to the terms of the notes,
we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject
such changes, in which case we may reject your offer to purchase.
You should read this pricing supplement together
with the accompanying prospectus, as supplemented by the accompanying prospectus supplement, relating to our Series A medium-term
notes of which these notes are a part, and the more detailed information contained in the accompanying product supplement and the
accompanying underlying supplement. This pricing supplement, together with the documents listed below, contains the terms of the
notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary
or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, fact sheets, brochures
or other educational materials of ours. You should carefully consider, among other things, the matters set forth in the “Risk
Factors” sections of the accompanying product supplement and the accompanying underlying supplement, as the notes involve
risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other
advisers before you invest in the notes.
PS-
10
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
You may access these documents on the SEC
website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):
Our Central Index Key, or CIK, on the SEC website
is 1665650, and JPMorgan Chase & Co.’s CIK is 19617. As used in this pricing supplement, “we,” “us”
and “our” refer to JPMorgan Financial.
PS-
11
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
Annex A
The iShares
®
China Large-Cap
ETF
All information contained in this pricing
supplement regarding the iShares
®
China Large-Cap ETF (the “FXI Fund”) has been derived from publicly
available information, without independent verification. This information reflects the policies of, and is subject to change by
iShares
®
Trust and BlackRock Fund Advisors (“BFA”). The FXI Fund is an investment portfolio of iShares
®
Trust. BFA is currently the investment adviser to the FXI Fund. The FXI Fund is an exchange-traded fund that trades on the NYSE
Arca, Inc. under the ticker symbol “FXI.”
The FXI Fund seeks to track the investment
results, before fees and expenses, of an index composed of large-capitalization Chinese equities that trade on the Stock Exchange
of Hong Kong Ltd. (“HKSE”), which is currently the FTSE
®
China 50 Index. For additional information
about the FXI Fund, see the information set forth under “Fund Descriptions — The iShares
®
ETFs”
in the accompanying underlying supplement. For the purposes of the accompanying underlying supplement, the FXI Fund is an “iShares
®
ETF.”
The
FTSE
®
China 50 Index
All information contained in this pricing supplement regarding
the FTSE
®
China 50 Index, including, without limitation, its make-up, method of calculation and changes in its components,
has been derived from publicly available information. This information reflects the policies of, and is subject to change by FTSE
International Limited (“FTSE”). FTSE has no obligation to continue to publish, and may discontinue publication of,
the FTSE
®
China 50 Index.
The FTSE
®
China 50 Index is reported by Bloomberg
L.P. under the ticker symbol “XINOI.”
The FTSE
®
China 50 Index is an index calculated,
published and disseminated by FTSE Russell. Frank Russell is a trading name of FTSE, Frank Russell Company, FTSE TMX Global Debt
Capital Markets Inc., FTSE TMX Global Debt Capital Markets Limited and MTSNext Limited. Originally launched in 2001 as the FTSE
®
China 25 Index, the index was expanded effective on September 22, 2014 to 50 stocks and renamed the FTSE
®
China
50 Index. The FTSE
®
China 50 Index is designed to represent the performance of the mainland Chinese market that
is available to international investors.
Composition of the FTSE
®
China 50 Index
The FTSE
®
China 50 Index is currently based
on the 50 largest and most liquid Chinese stocks (called “H” shares, “Red Chip” shares and “P Chip”
shares), listed and trading on the HKSE. “H” shares are securities of companies incorporated in the People’s
Republic of China and listed on the HKSE. “Red Chip” shares are securities of companies listed on the HKSE and incorporated
outside of the People’s Republic of China, but that are substantially owned directly or indirectly by the Chinese government
and that have over 55% of their revenue or assets derived from mainland China. “P Chip” shares are securities of companies
listed on the HKSE and incorporated outside of the People’s Republic of China, but that are controlled by mainland China
individuals, with the establishment and origins of the company in mainland China and that have over 55% of its revenue or assets
derived from mainland China.
Standards for Listing and Maintenance
Currently, only H shares, Red Chip and P Chip shares are eligible
for inclusion in the FTSE
®
China 50 Index. All classes of equity in issue are eligible for inclusion in the FTSE
®
China 50 Index, subject to certain restrictions; however, each constituent must also be a constituent of the FTSE
®
All-World Index. The FTSE
®
All-World Index is a market-capitalization weighted index designed to represent the performance
of the large- and mid-capitalization stocks from the FTSE
®
Global Equity Index Series and covers approximately 90%
to 95% of the world’s investable market capitalization. Companies whose business is that of holding equity and other investments
(
e.g.
, investment trusts) are not eligible for inclusion.
Securities must be sufficiently liquid to be traded; therefore,
the following criteria, among others, are used to ensure that illiquid securities are excluded:
•
Price
. There must be an accurate and reliable
price for the purposes of determining the market value of a company. The FTSE
®
China 50 Index uses the last trade
prices from the HKSE, when available.
•
Liquidity
. Each security is tested for
liquidity on a semi-annual basis in March and September by calculation of its median daily trading per month as part of the FTSE
All-World Index review. When calculating the median of daily trades per month of any security, a minimum of 5 trading days in each
month must exist, otherwise the month will be excluded from the test. The median trade is calculated by ranking each daily trade
total and selecting the middle-ranking day. Daily totals with zero trades are included in the ranking; therefore, a security that
fails to trade for more than half of the days in a month will have a zero median trade. Any period of
PS-
12
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
suspension will not be included in the test. The liquidity
test will be applied on a pro-rata basis where the testing period is less than 12 months.
•
New Issues
. New issues that do not have
a twelve-month trading record must have a minimum three-month trading record when reviewed. They must turnover at least 0.05% of
their free float adjusted shares based on their median daily trading volume each month, on a pro rata basis since their listing.
The FTSE
®
China 50 Index, like other indices
of FTSE, is governed by an independent advisory committee, the FTSE Asia Pacific Regional Committee, that ensures that the FTSE
®
China 50 Index is operated in accordance with its published ground rules, and that the rules remain relevant to the FTSE
®
China 50 Index. The FTSE Asia Pacific Regional Committee is responsible for undertaking the review of the FTSE
®
China 50 Index and for approving changes of constituents.
Computation of the FTSE
®
China 50 Index
The FTSE
®
China 50 Index is calculated using
the free float index calculation methodology of the FTSE Group. The FTSE
®
China 50 Index is calculated using the
following formula:
where “N” is the number of securities in the FTSE
®
China 50 Index, “
p
” is the latest trade price of the component security “
i
,” “
e
”
is the exchange rate required to convert the security’s home currency into the FTSE
®
China 50 Index’s
base currency, “
s
” is the number of shares of the security in issue, “
f
” is the free float
factor published by FTSE, to be applied to such security to allow amendments to its weighting, “
c
” is the capping
factor published by FTSE at the most recent quarterly review of the FTSE
®
China 50 Index, and “
d
”
is the divisor, a figure that represents the total issued share capital of the FTSE
®
China 50 Index at the base
date, which may be adjusted to allow for changes in the issued share capital of individual securities without distorting the FTSE
®
China 50 Index. The capping factor serves to limit the weight of any individual company to no more than 9% of the FTSE
®
China 50 Index and to limit the aggregate weight of all companies that have a weight greater than 4.5% to no more than 38% of the
FTSE
®
China 50 Index.
The FTSE
®
China 50 Index uses actual trade prices
for securities with local stock exchange quotations and Reuters real-time spot currency rates for its calculations. Under this
methodology, FTSE excludes from free floating shares: (i) shares held by public companies or by non-listed subsidiaries of public
companies; (ii) shares held by founders, and by directors and/or their families; (iii) employee share plans; (iv) government holdings;
(v) foreign ownership limits; (vi) portfolio investments subject to lock-in clauses (for the duration of the clause); (vii) shares
held by sovereign wealth funds where each holding is 10% or greater; (viii) shares held for publicly announced strategic reasons;
and (ix) shares that are subject to on-going contractual agreements (such as swaps) where they would ordinarily be treated as restricted.
Free float restrictions are calculated using available published
information. For shares of companies that have a free float greater than 5%, the actual free float will be rounded up to the next
highest whole percentage number. Companies with a free float 5% or below are not eligible for inclusion in the index. Following
the application of an initial free float restriction, a constituent’s free float will only be changed if its rounded free
float moves to more than 3 percentage points above or below the existing rounded float. Once a company’s actual free float
moves about 99%, the free float will be rounded to a 100%. A constituent with a free float of 15% or below will not be subject
to the 3 percentage points threshold.
Foreign ownership limits, if any, are applied after calculating
the actual free float restriction. If the foreign ownership limit is more restrictive than the free float restriction, the precise
foreign ownership limit is applied. If the foreign ownership limit is less restrictive or equal to the free float restriction,
the free float restriction is applied.
The FTSE
®
China 50 Index is periodically reviewed
for changes in free float. These reviews coincide with the quarterly reviews undertaken of the FTSE
®
China 50 Index.
Implementation of any changes takes place at the close of trading on the third Friday in March, June, September and December. A
stock’s free float is also reviewed and adjusted if necessary following certain corporate events. If the corporate event
includes a corporate action which affects the FTSE® China 50 Index, any change in free float is implemented at the same time
as the corporate action. If there is no corporate action, the change in free float is applied as soon as practicable after the
corporate event.
PS-
13
| Structured Investments
Review Notes Linked to the Lesser Performing of the iShares
®
MSCI Emerging Markets ETF and the iShares
®
China Large-Cap ETF
|
|
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Mar 2024 to Apr 2024
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Apr 2023 to Apr 2024